Simulated effects of early menopausal bone mineral density preservation on long-term fracture risk: a feasibility study
ConclusionInfrequent infusions of zoledronic acid, initiated early in menopause, are expected to reduce long-term fracture risk and result in a substantial reduction in the proportion of women with densitometric osteoporosis after age 65.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research
More News: Canada Health | Men | Menopause | Orthopaedics | Osteoporosis | Reclast | Sports Medicine | Study | Women | Zometa